Spinal Cord Injury: Clinical Trials

32 trials for Spinal Cord Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 4 terminated, 2 withdrawn, 1 not yet recruiting. 32 Phase 3, 18 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 332Completed 23, Terminated 4, Withdrawn 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 218Completed 12, Terminated 3, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Spinal Cord Injury: new trials by email Literature Review of Spinal Cord Injury trials Research Report on Spinal Cord Injury

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Galantamine Hydrobromide Extended Release - Spinal Cord Injury, Traumatic Spinal Cord Injury
Phase 2 / Phase 3RecruitingNorthwell Health602026-06-152026-06-04
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
NMES, Vitamin D, Passive movement - Spinal Cord Injury
Phase 2 / Phase 3CompletedVA Office of Research and Development62021-10-012026-01-23
Treatment of Post-SCI Hypotension
Midodrine Hydrochloride - Spinal Cord Injury, Autonomic Dysreflexia
Phase 2 / Phase 3CompletedJames J. Peters Veterans Affairs Medical Center662017-06-012025-02-21
Cethrin in Acute Cervical Spinal Cord Injury
Cethrin (BA-210), Placebo - Spinal Cord Injury
Phase 2 / Phase 3WithdrawnBioAxone BioSciences, Inc.2015-07-012014-11-26
Fenofibrate Treatment in SCI
Fenofibrate, No intervention - Spinal Cord Injury, Dyslipidemia
Phase 2 / Phase 3CompletedVA Office of Research and Development232015-05-182019-06-26
Blood Pressure, Cerebral Blood Flow and Cognition in Spinal Cord Injury
Midodrine, Placebo - Spinal Cord Injury
Phase 3CompletedJames J. Peters Veterans Affairs Medical Center192014-03-012025-02-21
Riluzole in Spinal Cord Injury Study
Riluzole, Placebo - Spinal Cord Injury
Phase 2 / Phase 3TerminatedAOSpine North America Research Network1932013-10-012021-04-19
Robotic Gait Training VS.Conventional Rehabilitation in SCI
Robot gait training, control - Spinal Cord Injury
Phase 3UnknownPrasat Neurological Institute162013-01-012012-07-17
Zoledronic Acid in Acute Spinal Cord Injury
Zoledronic acid, normal saline 0.9% - Spinal Cord Injury
Phase 3CompletedThomas Jefferson University162012-09-012023-05-23
Resistance Training and Testosterone After Spinal Cord Injury
Resistance Training and Testosterone Patches, Testosterone Patches - Spinal Cord Injury
Phase 2 / Phase 3CompletedVA Office of Research and Development262012-07-022018-05-03
Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China
cell therapy, rehabilitation - Spinal Cord Injury
Phase 3CompletedGeneral Hospital of Chinese Armed Police Forces3002012-06-012018-05-25
Study of the Impact of the Use of a Corset on the Respiratory Function of Patients With Spinal Cord Injury
Corset - Spinal Cord Injury, Tetraplegia
Phase 3WithdrawnAssistance Publique - Hôpitaux de Paris2012-03-012013-12-19
Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury
GH, Placebo - Spinal Cord Injury
Phase 3CompletedHospital Nacional de Parapléjicos de Toledo762011-04-012022-05-31
SCIPA Full-On :Intensive Exercise Program After Spinal Cord Injury
Therastride Treadmill System, FES-assisted cycling, Trunk and upper and lower limb exercises - Spinal Cord Injury
Phase 3CompletedUniversity of Melbourne1162010-12-012021-05-03
Study on Functional Electrical Stimulation (FES) Cycling Following Spinal Cord Injury
FES Cycling, Cycling without FES, Lumbar puncture - Spinal Cord Injury
Phase 2 / Phase 3TerminatedHugo W. Moser Research Institute at Kennedy Krieger, Inc.112010-10-012021-01-27
Spinal Cord Injury Energy Management Program
Energy Management Program - Spinal Cord Injury
Phase 2 / Phase 3CompletedUniversity of British Columbia282010-08-012014-03-17
The Effects of Two Functional Electrical Stimulation Cycling Paradigms
Cycling with functional electrical stimulation - Spinal Cord Injury
Phase 2 / Phase 3CompletedThomas Jefferson University172010-07-012014-01-08
Early Intensive Hand Rehabilitation After Spinal Cord Injury
ReJoyce Workstation, Standard Care - Spinal Cord Injury
Phase 3CompletedUniversity of Melbourne702009-09-012021-05-03
Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury
cellgram-spine - Spinal Cord Injury
Phase 2 / Phase 3TerminatedPharmicell Co., Ltd.202008-08-012021-03-23

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Spinal Cord Injuries (32)  ·  Quadriplegia (6)  ·  Paraplegia (4)  ·  Hypotension, Orthostatic (3)  ·  Muscle Spasticity (3)  ·  Wounds and Injuries (3)  ·  Hypogonadism (2)  ·  Hypotension (2)  ·  Autonomic Dysreflexia (1)  ·  Bone Diseases (1)  ·  Bone Resorption (1)  ·  Central Nervous System Diseases (1)  ·  Dyslipidemias (1)  ·  Endocrine System Diseases (1)  ·  Erectile Dysfunction (1)

Broader conditions

Central Nervous System Diseases (31)  ·  Nervous System Diseases (31)  ·  Spinal Cord Diseases (31)  ·  Trauma, Nervous System (31)  ·  Wounds and Injuries (29)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Signs and Symptoms (11)  ·  Neurologic Manifestations (9)  ·  Paralysis (5)  ·  Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Autonomic Nervous System Diseases (3)  ·  Muscle Hypertonia (3)  ·  Muscular Diseases (3)  ·  Musculoskeletal Diseases (3)

Interventions

4-Aminopyridine (2)  ·  Methylprednisolone (2)  ·  Midodrine (2)  ·  Cell- and Tissue-Based Therapy (1)  ·  Electric Stimulation Therapy (1)  ·  Erythropoietin (1)  ·  Fenofibrate (1)  ·  Finasteride (1)  ·  Galantamine (1)  ·  Human Growth Hormone (1)  ·  Methods (1)  ·  NG-Nitroarginine Methyl Ester (1)  ·  Range of Motion, Articular (1)  ·  Rehabilitation (1)  ·  Resistance Training (1)

Sponsors

VA Office of Research and Development (5)  ·  US Department of Veterans Affairs (3)  ·  Acorda Therapeutics (2)  ·  James J. Peters Veterans Affairs Medical Center (2)  ·  Thomas Jefferson University (2)  ·  University of Melbourne (2)  ·  AOSpine North America Research Network (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bayer (1)  ·  BioAxone BioSciences, Inc. (1)  ·  Elan Pharmaceuticals (1)  ·  General Hospital of Chinese Armed Police Forces (1)  ·  Hospital Nacional de Parapléjicos de Toledo (1)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)

Countries

United States (18)  ·  Canada (5)  ·  Australia (3)  ·  New Zealand (2)  ·  China (1)  ·  Italy (1)  ·  Japan (1)  ·  South Korea (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

William Bauman, MD (2)  ·  Andrea Townson, Dr. (1)  ·  Andrew Blight (1)  ·  Andrew Blight, MD (1)  ·  Antonio Oliviero, MD, PhD (1)  ·  Arthur Prochazka (1)  ·  Ashraf Gorgey, PhD PT (1)  ·  Branko Kopjar, MD, PhD (1)  ·  Christina V Oleson, MD (1)  ·  Daniel Becker, M.D. (1)  ·  Dora E Ifon, PhD (1)  ·  Dr Andrew Nunn (1)  ·  Dr Tim Geraghty (1)  ·  Edelle C Field-Fote, PT, PhD (1)

Results publications

PMID 16398945, PMID 17046161, PMID 17213237, PMID 17385265, PMID 17475549, PMID 17965289, PMID 19648013, PMID 19651280, PMID 19799783, PMID 21252493, PMID 21372246, PMID 21674390, PMID 21675354, PMID 21717386, PMID 21762873, PMID 22985379, PMID 23295632, PMID 23343764, PMID 23700789, PMID 24968251, PMID 26394202, PMID 26705884, PMID 27008910, PMID 27901413, PMID 28864949, PMID 28948164, PMID 28970100, PMID 30794084, PMID 30845047, PMID 32203065, PMID 32352341, PMID 33177997, PMID 33443609, PMID 34713983, PMID 35366432, PMID 35545824, PMID 37130044, PMID 37279301, PMID 38712567, PMID 39446982